+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID06477185

Evaluating Doxycycline to Prevent Lung Scarring and Improve Breathing in Adults with Advanced Pulmonary Tuberculosis in a Double-Blind Randomized Trial

Led by Makerere University · Updated on 2025-04-17

200

Participants Needed

2

Research Sites

49 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether doxycycline, a drug that inhibits enzymes causing lung damage, can prevent lung fibrosis and decline in lung function among patients with advanced drug-sensitive pulmonary tuberculosis TB. The study aims to determine if doxycycline, given alongside standard TB treatment, has a significant anti-fibrosis effect compared to a placebo. This is a double-blind, randomized, placebo-controlled clinical trial focused on TB patients with advanced lung involvement. Participants will be randomly assigned to receive either 100 mg of doxycycline or a matching placebo once daily for 12 weeks, both given with standard anti-TB therapy. The study includes baseline and 12-month high-resolution CT scans to assess lung fibrosis. Lung function tests using spirometry will be performed at 6 and 12 months. Blood samples will be taken at baseline, 3 months, and 6 months to measure markers related to fibrosis and inflammation. During the study, participants will have scheduled visits for scans, lung function tests, and blood draws to monitor changes and compare outcomes between the doxycycline and placebo groups. Researchers will assess lung fibrosis scores, lung function trends, and levels of specific cytokines and enzymes over a 12-month period. The trial monitors participants health and treatment adherence throughout the study period to evaluate the effectiveness of doxycycline in preventing TB-associated lung damage.

CONDITIONS

Brief Title

Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline

Research Team

A

Ahmed Ddungu, MBCHB,MMED

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here